TRCT
CLGN icon

Tower Research Capital (TRC)’s CollPlant Biotechnologies CLGN Stock Holding History

Tower Research Capital (TRC)’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1
Closed -$5 – 5734
2024
Q2 		$5 Buy
+1
New +$6 ﹤0.01% 5615
2022
Q3 		– Sell
-892
Closed -$7K – 6100
2022
Q2 		$7K Buy
+892
New +$8.19K ﹤0.01% 4770
2021
Q4 		– Sell
-86
Closed -$1K – 6172
2021
Q3 		$1K Sell
86
-511
-86% -$9.18K ﹤0.01% 5437
2021
Q2 		$13K Buy
+597
New +$9.54K ﹤0.01% 4215

Other funds holding CLGN

PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $10.1B AUM 14.03% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tower Research Capital (TRC)'s CLGN Position: Q3 2024 in Review

Tower Research Capital (TRC) sold out of CollPlant Biotechnologies (CLGN) in Q3 2024, closing a stake of 1 share — an estimated $5 sold.

Tower Research Capital (TRC) first reported a position in CLGN in Q2 2021 and held it in 4 quarters. The position peaked at $13K in Q2 2021. 13 funds tracked by Wall St. Rank hold CLGN as of Q3 2024.

  • Tower Research Capital (TRC) reported no remaining CollPlant Biotechnologies position as of Q3 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1 CollPlant Biotechnologies share in Q3 2024, an estimated $5.
  • Tower Research Capital (TRC) first reported a position in CollPlant Biotechnologies in Q2 2021 and held it in 4 quarters.
  • Tower Research Capital (TRC)'s CollPlant Biotechnologies position peaked at $13K in Q2 2021.
  • 13 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2024, filed 14 Nov 2024.